膜杰作
Star Staining
抗体来源（Source）
Monoclonal Anti-RSV-post-F0 specific Antibody, Human IgG1 (1A2D9D8) is a chimeric monoclonal antibody recombinantly expressed from HEK293, which combines the variable region of a mouse monoclonal antibody with Human constant domain.
克隆号（Clone）
1A2D9D8
亚型（Isotype）
Human IgG1 | Kappa
偶联（Conjugate）
Unconjugated
抗体类型（Antibody Type）
Recombinant Monoclonal
种属反应性（Reactivity）
Virus
免疫原（Immunogen）
Recombinant HRSV (A) Fusion glycoprotein F0 derived from human 293 cells.
特异性（Specificity）
This product is a specific antibody specifically reacts with RSV-post-F0.
应用（Application）
| Application | Recommended Usage |
| ELISA | 0.1-500 ng/mL |
纯度（Purity）
>90% as determined by SDS-PAGE.
纯化（Purification）
Protein A purified/ Protein G purified
制剂（Formulation）
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重构方法（Reconstitution）
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存储（Storage）
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
电泳（SDS-PAGE）
Monoclonal Anti-RSV-post-F0 specific Antibody, Human IgG1 (1A2D9D8) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).
活性（Bioactivity）-ELISA
Immobilized HRSV (A) Post-fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H6) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-RSV-post-F0 specific Antibody, Human IgG1 (1A2D9D8) (Cat. No. RSV-M662) with a linear range of 0.1-16 ng/mL. HRSV (A) Pre-fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H7) is verified not recoginized by Monoclonal Anti-RSV-post-F0 Antibody, Human IgG1 (1A2D9D8) (Cat. No. RSV-M662) in low concentration (QC tested).
Protocol
背景（Background）
Human respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. The RSV fusion glycoprotein (RSV F) is the principal target of RSV neutralizing antibodies in human sera. The RSV F is a type I viral fusion protein synthesized as inactive, single-chain polypeptides that assemble into trimers. RSV F fuses the viral and host cell membranes by irreversible protein refolding from the labile prefusion conformation to the stable post-fusion conformation.
